Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By Test Types (Radiographic Method, Diagnostic Laboratory Methods, Nucleic Acid Testing, Phage Assay, Detection of Latent Infection), And Segment Forecasts, 2018 - 2024

Table of Content

Chapter 1 Research Methodology
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Market Summary
Chapter 4 Market Variables, Trends & Scope
4.1 Market Segmentation & Scope
4.2 Market Driver Analysis
4.3 Market Restraint Analysis
4.4 Penetration & Growth Prospect Mapping
4.5 SWOT Analysis, By Factor
4.5.1 Political
4.5.2 Economic
4.5.3 Technology
Chapter 5 Market Categorization 1: Test Types Estimates & Trend Analysis
5.1 Test Types Movement Analysis & Market Share, 2015 & 2024
5.2 Market Size & Forecasts and Trend Analyses, 2013 to 2024 for the following products:
5.2.1 Radiographic method
5.2.2 Diagnostic Laboratory methods
5.2.2.1 Smear microscopy
5.2.2.2 Culture-based test
5.2.3 Nucleic acid testing
5.2.4 Phage assay
5.2.5 Detection of latent infection
5.2.6 Cytokine detection assay
5.2.7 Detection of drug resistance
5.2.8 Other methods
Chapter 6 Market Categorization 2: Regional Estimates & Trend Analysis
6.1 Regional Movement Analysis & Market Share, 2015 & 2024
6.2 Market Size & Forecasts and Trend Analyses, 2013 to 2024 for the following regions:
6.2.1 North America
6.2.1.1 The U.S.
6.2.1.2 Canada
6.2.2 Europe
6.2.2.1 U.K.
6.2.2.2 Russian Fedration
6.2.3 Asia Pacific
6.2.3.1 China
6.2.3.2 India
6.2.4 Latin America
6.2.4.1 Brazil
6.2.4.2 Mexico
6.2.5 MEA
6.2.5.1 South Africa
Chapter 7 Competitive Landscape
7.1 Strategy Framework
7.2公司简介
7.2.1 Abbott Laboratories
7.2.1.1 Company Overview
7.2.1.2 Financial Performance
7.2.1.3 Product Benchmarking
7.2.1.4 Strategic Initiatives
7.2.2 Alere, Inc.
7.2.2.1 Company Overview
7.2.2.2 Financial Performance
7.2.2.3 Product Benchmarking
7.2.2.4 Strategic Initiatives
7.2.3 Becton, Dickinson and Company
7.2.3.1 Company Overview
7.2.3.2 Financial Performance
7.2.3.3 Product Benchmarking
7.2.3.4 Strategic Initiatives
7.2.4 F.Hoffmann-La Roche AG
7.2.4.1 Company Overview
7.2.4.2 Financial Performance
7.2.4.3 Product Benchmarking
7.2.4.4战略举措
7.2.5 Siemens
7.2.5.1 Company Overview
7.2.5.2 Financial Performance
7.2.5.3 Product Benchmarking
7.2.5.4 Strategic Initiatives
7.2.6 bioMérieux SA
7.2.6.1 Company Overview
7.2.6.2 Financial Performance
7.2.6.3 Product Benchmarking
7.2.6.4 Strategic Initiatives
7.2.7 Cepheid
7.2.7.1 Company Overview
7.2.7.2 Financial Performance
7.2.7.3产品Benchmarking
7.2.7.4 Strategic Initiatives
7.2.8 Hain Lifesciences GmBH
7.2.8.1 Company Overview
7.2.8.2 Financial Performance
7.2.8.3 Product Benchmarking
7.2.8.4 Strategic Initiatives
7.2.9 Hologic Corporation
7.2.9.1 Company Overview
7.2.9.2 Financial Performance
7.2.9.3 Product Benchmarking
7.2.9.4 Strategic Initiatives

List of Tables

TABLE 1 North America tuberculosis disgnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 2 North America diagnostic laboratory methods market, by type, 2013 - 2024 (USD Million)
TABLE 3 U.S. tuberculosis disgnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 4 U.S. diagnostic laboratory methods market, by type, 2013 - 2024 (USD Million)
TABLE 5 Canada tuberculosis disgnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 6 Canada diagnostic laboratory methods market, by type, 2013 - 2024 (USD Million)
TABLE 7 Europe tuberculosis disgnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 8 Europe diagnostic laboratory methods market, by type, 2013 - 2024 (USD Million)
TABLE 9 UK tuberculosis disgnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 10 UK diagnostic laboratory methods market, by type, 2013 - 2024 (USD Million)
TABLE 11 Russian Federation tuberculosis disgnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 12 Russian Federationdiagnostic laboratory methods market, by type, 2013 - 2024 (USD Million)
TABLE 13 Asia Pacific tuberculosis disgnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 14 Asia Pacific diagnostic laboratory methods market, by type, 2013 - 2024 (USD Million)
TABLE 15 China tuberculosis disgnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 16 China diagnostic laboratory methods market,by type, 2013 - 2024 (USD Million)
TABLE 17 India tuberculosis disgnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 18 India diagnostic laboratory methods market, by type, 2013 - 2024 (USD Million)
TABLE 19 Latin America tuberculosis disgnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 20 Latin America diagnostic laboratory methods market, by type, 2013 - 2024 (USD Million)
TABLE 21 Brazil tuberculosis disgnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 22 Brazil diagnostic laboratory methods market, by type, 2013 - 2024 (USD Million)
TABLE 23 Mexico tuberculosis disgnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 24 Mexico diagnostic laboratory methods market, by type, 2013 - 2024 (USD Million)
TABLE 25 MEA tuberculosis disgnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 26 MEA diagnostic laboratory methods market, by type, 2013 - 2024 (USD Million)
TABLE 27 South Africa tuberculosis disgnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 28 South Africa diagnostic laboratory methods market, by type, 2013 - 2024 (USD Million)

List of Figures

FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint relevance analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 8 Porter’s Five Forces Analysis
FIG. 9 Tuberculosis diagnostics market device test type outlook:Key takeaways
FIG. 10 Tuberculosis diagnostics : Test type movement analysis
FIG. 11 Radiographic method market, 2013 - 2024 (USD Million)
FIG. 12 Diagnostic laboratory methods market, 2013 - 2024 (USD Million)
FIG. 13 Smear microscopy market, 2013 - 2024 (USD Million)
FIG. 14 Culture-based tests market, 2013 - 2024 (USD Million)
FIG. 15 Nucleic acid testing market, 2013 - 2024 (USD Million)
FIG. 16 Phage assay method market, 2013 - 2024 (USD Million)
FIG. 17 Detection of latent infection market, 2013 - 2024 (USD Million)
图18 Cytokine detection assay market, 2013 - 2024 (USD Million)
FIG. 19 Detection of drug resistance market, 2013 - 2024 (USD Million)
FIG. 20 North America tuberculosis diagnostics market, 2013 - 2024 (USD Million)
FIG. 21 U.S. tuberculosis diagnostics market, 2013 - 2024 (USD Million)
FIG. 22 Canada tuberculosis diagnostics market, 2013 - 2024 (USD Million)
FIG. 23 Europe tuberculosis diagnostics market, 2013 - 2024 (USD Million)
FIG. 24 UK tuberculosis diagnostics market, 2013 - 2024 (USD Million)
FIG. 25 Russian Federation tuberculosis diagnostics market, 2013 - 2024 (USD Million)
FIG. 26 Asia Pacific tuberculosis diagnostics market, 2013 - 2024 (USD Million)
FIG. 27 China durable tuberculosis diagnostics market, 2013 - 2024 (USD Million)
FIG. 28 Indiatuberculosis diagnostics market, 2013 - 2024 (USD Million)
FIG. 29 Latin America tuberculosis diagnostics market, 2013 - 2024 (USD Million)
FIG. 30 Brazil tuberculosis diagnostics market, 2013 - 2024 (USD Million)
FIG. 31 Mexico tuberculosis diagnostics market, 2013 - 2024 (USD Million)
FIG. 32 MEA tuberculosis diagnostics market, 2013 - 2024 (USD Million)
FIG. 33 South Africa tuberculosis diagnostics market, 2013 - 2024 (USD Million)